Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company trades pharmaceutical medicines at retail and wholesale.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 14,316 | 12,666 | 16,525 | 20,115 | 21,532 | 22,814 | 23,876 | +8.9% | |
| Total COGS | 12,424 | 10,141 | 12,238 | 13,507 | 13,169 | 13,564 | 12,793 | +0.5% |
| Gross Profit | 1,891 | 2,525 | 4,287 | 6,608 | 8,364 | 9,250 | 11,083 | +34.3% |
| Gross Margin | 13.2% | 19.9% | 25.9% | 32.9% | 38.8% | 40.5% | 46.4% | |
| 2,884 | 2,278 | 4,612 | 5,467 | 7,940 | 8,478 | 9,515 | +22.0% | |
| EBITDA | 993 | 247 | 325 | 1,141 | 423 | 772 | 1,568 | nmf |
| EBITDA Margin | 6.9% | 2.0% | 2.0% | 5.7% | 2.0% | 3.4% | 6.6% | |
| Total D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT / Operating Income | 993 | 247 | 325 | 1,141 | 423 | 772 | 1,568 | nmf |
| Total Interest Expense | 0 | 0 | 79 | 74 | 128 | 118 | 111 | +9.1% |
| 3 | 84 | 2 | 43 | 0 | 0 | 0 | +134.2% | |
| Profit Before Tax | 989 | 164 | 402 | 1,110 | 296 | 654 | 1,457 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 993 | 164 | 352 | 1,141 | 296 | 654 | 1,457 | nmf |
| Net Margin | 6.9% | 1.3% | 2.1% | 5.7% | 1.4% | 2.9% | 6.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →